Xermelo

Active Ingredient(s): Telotristat Ethyl
FDA Approved: * February 28, 2017
Pharm Company: * LEXICON PHARMA INC
Category: Gastrointestinal

Telotristat ethyl (USAN, brand name Xermelo) is a prodrug of telotristat, which is an inhibitor of tryptophan hydroxylase. It is formulated as telotristat etiprate — a hippurate salt of telotristat ethyl.[1] On February 28, 2017, the U.S. Food and Drug Administration (FDA) approved telotristat ethyl in combination with somatostatin analog (SSA) therapy for the treatment of adults with diarrhea associated with carcinoid syndrome that SSA therapy alone has inadequately con... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xermelo 250 mg Oral Tablet
NDC: 70183-125
Labeler:
Lexicon Pharmaceuticals, Inc.
Xermelo 250 mg Oral Tablet
NDC: 70720-125
Labeler:
Tersera Therapeutics LLC